We released to the public: sinusitis acute and chronic; nephrotic and nephritic syndromes, mentruation, pregnancy, and others.
We released to the public improved angina, coronary syndromes, like: stable coronary artery disease, ST-elevation myocardial infarction (MI) and non-ST-elevation MI. Improved modeling. Improved pancreatitis. Corrected multiple typos and language issues. Added symptom checker bot, text message chat like – free to use with any CMS / website. Improved suggestions.
Released to public risk of life-threatening symptoms gauge within the symptom checker.
We released to the public: CVAs (i.e. sub-arachnoid hemorrhage, ischemic and hemorrhagic strokes), primary headaches (migraines, tension headaches, cluster headaches), secondary headaches (from nitrates, from caffeine withdrawal), PVD (ischemic extremity, ischemic colitis, and mesenteric ischemia), chest pain etiologies (from pulmonary emboli, via aortic dissections, to NSTEMI and STEMI), more heart failure syndromes (myocarditis for example), more secondary hypertension (from obstructive sleep apnea, obesity, hyperaldosteronism), more abdominal pains (from ectopic and healthy pregnancy, via ischemic bowel, to Clostridium diff. colitis).
We released to the public: Vaginal candidiasis, urethritis, hydronephrosis, other STDs with gonococcal and chlamydial urethritis, trichomonas—all with further improved modeling.
We released to the public: the first set of multiple-choice “USMLE-style” board questions almost entirely generated by AI of EndlessMedicalAPI (including cases of COVID-19, asthma, chronic obstructive disease exacerbation, community-acquired pneumonia, and healthcare-associated pneumonia. This is the first known to us successful attempt to make AI generate educational MCQ questions. The explanations were also created by the AI, although still required significant editing for appropriate English at this point.
Released to the public: diabetes mellitus type 1 and 2, primary arterial hypertension, and secondary arterial hypertension (secondary to hyperaldosteronism, secondary to CKD, obesity, and OSA), hypoxia, transaminitis, hepatitis C, and both diabetic and hypertensive kidney diseases.
The new version of the modeling has been uploaded to the API server. It resembles the “real” patient’s encounters more now.
We have added: “COVID toes” to the features’ list in our system.
Based on recent publication: “Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia”. Zhang Y, Cao W, Xiao M, Li YJ, Yang Y, Zhao J, Zhou X, Jiang W, Zhao YQ, Zhang SY, Li TS. 2020 Mar 28;41(0):E006. doi: 10.3760/cma.j.issn.0253-2727.2020.0006, we added “Limb tips fingers/toes ischemic signs on the skin (i.e., acro-cyanosis, bullae, dry gangrene)” symptoms for respective COVID-19 positive patients.
This feature will be incorporated into other diseases with similar symptoms in our database, like limb ischemia, arterial thrombosis, embolization, and others.
We have added both: atherosclerotic and embolic lower extremities ischemia to diseases list, with arterial Dopplers and ABI as recommended tests, with symptoms like claudication, ischemic skin changes, and others – so the “COVID toes” don’t function in the void, and can be effectively differentiated, from other etiologies of ischemic skin changes by EndlessMedical.com API.
We added new features of “Loss of smell.”, and “Loss of taste.”.
These were recently added by WHO to symptoms of Covid-19, based on the publication: Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Carol H. Yan MD, Farhoud Faraji MD Ph.D., Divya P. Prajapati BS, Christine E. Boone MD Ph.D., Adam S DeConde MD, First published: 12 April 2020, https://doi.org/10.1002/alr.22579.
We added a new disease, the ‘Common cold.’
We have added two tests, which are commonly done in patients with the clinical diagnosis of pneumonia: ‘Pneumococcal urine antigen’ and ‘Legionella urine antigen.’ These are done in Covid-19 patients, to not miss treatable coinfection.
Our technology covering patent application is now published (USA USPTO # 20200118691 and international PCT/US2019/055747).
We’ve added https support for our website and for the Endless Medical API
Updated Covid-19 definition to better incorporate PLTs (platelets level) and Temp (Maximal recorded temperature) into modeling.
We reached more than 1000 calls via RapidAPI – thank you for your questions, requests, and support in these difficult times.
Upgraded engine, to be more sensitive to small variable changes. This is more consistent with the “real life” simulation of the provider-patient encounters scenario.
Updated the COVID-19 exposure to reflect the most recent countries / exposure zones as per: https://www.cdc.gov/coronavirus/2019-ncov/travelers/after-travel-precautions.html level 2 and 3 countries.
Added change logging feature to keep developers in the loop.